51
Participants
Start Date
July 29, 2019
Primary Completion Date
November 16, 2022
Study Completion Date
February 25, 2031
PF-06838435/ fidanacogene elaparvovec
Gene Therapy
Changhua Christian Hospital, Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Royal Prince Alfred Hospital, Camperdown
The Alfred Hospital, Melbourne
Royal Brisbane and Women's Hospital, Herston
Royal Adelaide Hospital, Adelaide
Fiona Stanley Hospital, Murdoch
National Taiwan University Hospital, Taipei
Vivantes Klinikum Friedrichshain, Berlin
Vivantes Klinikum im Friedrichshain, Berlin
"General Hospital of Athens LAIKO, 2nd Regional Blood Transfusion Center", Athens
King Abdulaziz Medical City-Ministry of national guard, Riyadh
Center for Human Phenomic Science CHPS, Philadelphia
Center for Human Phenomic Science, Philadelphia
Investigational Drug Service, Philadelphia
Penn Blood Disorder Center, Philadelphia
Gaziantep University Sahinbey Training and Research Hospital, Gaziantep
Hospital Universitario Virgen de la Arrixaca, El Palmar
Istanbul University Oncology Institute, Istanbul
Ege University Medical Faculty Hospital, Izmir
Madison Radiological Group, Madison
Mississippi Center for Advanced Medicine, Madison
Chung Shan Medical University Hospital, Taichung
Chung Shan Medical University, Taichung
Taichung Veterans General Hospital, Taichung
Indiana Hemophilia & Thrombosis Center, Inc., Indianapolis
Indiana Hemophilia and Thrombosis Center, Inc, Indianapolis
St. Vincent Hospital & Health Care Center, Inc., Indianapolis
Azienda Ospedaliero Universitaria Careggi, Florence
Universitaetsklinikum Bonn, Bonn
Universitätsklinikum Bonn, Anstalt des öffentlichen Rechts, Bonn
Universitätsklinikum Bonn, Bonn
Hopital Cardiologique Louis Pradel - CRTH, Bron
Hopital Necker, Paris
Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus, Aurora
Azienda Ospedaliera Universitaria Federico II, Naples
University of California, San Francisco - Clinical Research Center, San Francisco
University of California, San Francisco - Outpatient Hematology Clinic, San Francisco
Centro Estadual de Hemoterapia e Hematologia Marcos Daniel Santos - Hemoes, Vitória
Centro de Hematologia e Hemoterapia - Hemocentro de Campinas - UNICAMP, Campinas
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti- HEMORIO, Rio de Janeiro
McMaster University Medical Centre - Hamilton Health Sciences, Hamilton
Juravinski Hospital - Hamilton Health Sciences, Hamilton
St. Michael's Hospital, Toronto
Sapporo Tokushukai Hospital, Sapporo
Nara Medical University Hospital, Kashihara
Saitama Medical University Hospital, Iruma-gun
National Center for Child Health and Development, Setagaya-ku
King Faisal Specialist Hospital and Research Centre, Riyadh
Kyung Hee University Hospital at Gangdong, Seoul
Hospital Universitari Vall d´Hebrón, Barcelona
Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Malmo
ApoEx AB, Malmo
Acibadem Adana Hospital, Adana
Newcastle upon Tyne Hospitals NHS FT, Newcastle upon Tyne
Newcastle upon Tyne Hospitals NHS FT, Newcastle upon Tyne
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Glasgow Royal Infirmary, Glasgow
Guy's and St. Thomas' NHS Foundation Trust, London
Lead Sponsor
Pfizer
INDUSTRY